{
  "docId": "019de073-dba4-758b-bcbe-08ad83e87d71",
  "docSlug": "afc13b14322819221680611098a4aee7",
  "documentTitle": "Third Harmonic Bio | Investor Presentation Deck | 20 slides",
  "authorId": "third-harmonic-bio",
  "authorName": "Third Harmonic Bio",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 17,
  "pageCount": 20,
  "prevPage": 16,
  "nextPage": 18,
  "slideType": "why_now",
  "function": "argue_timing",
  "density": "overcrowded",
  "nDataPoints": 2,
  "notes": "The slide combines mechanistic biological data (Maun et al.) with clinical trial results (Cahill et al., NEJM) to justify targeting mast cells in severe asthma.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-dba4-758b-bcbe-08ad83e87d71/17",
  "deckHref": "/decks/019de073-dba4-758b-bcbe-08ad83e87d71",
  "deckJsonHref": "/decks/019de073-dba4-758b-bcbe-08ad83e87d71.json",
  "deckAnchorHref": "/decks/019de073-dba4-758b-bcbe-08ad83e87d71#slide-17",
  "components": [
    {
      "bbox": {
        "h": 0.35,
        "w": 0.4,
        "x": 0.57,
        "y": 0.215
      },
      "kind": "callout",
      "text": "Gleevec (Imatinib) In Severe Refractory Asthma",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0f89b78a-4360-4562-966e-e0c422caef17",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.25,
        "x": 0.05,
        "y": 0.58
      },
      "kind": "chart",
      "text": "Lung Tryptase",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6f518f98-a130-4656-9c37-a421f257178e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.25,
        "x": 0.27,
        "y": 0.58
      },
      "kind": "chart",
      "text": "Plasma Tryptase",
      "attrs": null,
      "subkind": "box",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dd7af8e6-2238-4fa9-b68c-b63d0860c71f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.2,
        "x": 0.75,
        "y": 0.24
      },
      "kind": "image",
      "text": "NEJM Journal Header",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "efad1e6e-cfc7-486f-bf0e-079731825914",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.4,
        "x": 0.58,
        "y": 0.44
      },
      "kind": "list",
      "text": "Moderately potent KIT inhibitor\n43% reduction in serum tryptase --> significant improvements in FEV1 and airway hyperreactivity\nNon-endotype restricted study population\nProvides human PoC, even with suboptimal KIT inhibition",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "488f838b-9933-4da9-a277-4204a242690c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.48,
        "x": 0.037,
        "y": 0.18
      },
      "kind": "list",
      "text": "Asthma severity correlates with lung mast cell number, localization and phenotype\nMast cell changes are independent of biomarker status (i.e., blood eosinophils)\nMast cells required for IgE-dependent and -independent TSLP production in rodents",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "547a95f7-4f27-481b-bbaf-5df02f727ee7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.65,
        "x": 0.33,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "Maun, et al., Cell, October 2019; Cahill, et al., NEJM, May 2017",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f4dc9d72-f055-4adb-88a8-cbdbb6695c77",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.43,
        "x": 0.037,
        "y": 0.12
      },
      "kind": "title",
      "text": "Mast cells are central to asthma pathophysiology",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "83c91fec-2d8d-44cf-b18c-b487bef8e572",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.47,
        "x": 0.037,
        "y": 0.065
      },
      "kind": "title",
      "text": "Indication Expansion: Severe Asthma",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "576cc742-487f-4229-b59b-f52792c1ddce",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Audience Definition",
      "slug": "audience-definition",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "83e3c684-8e55-4994-a1d8-31a423ea0654",
      "evidence": "list/bullet: Asthma severity correlates with lung mast cell number, localization and phenotype",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "evidence-matrix",
      "slug": null,
      "matchId": "5ebc4e5f-0082-4a7b-918a-87cb52bd7398",
      "evidence": "Combines mechanistic data with clinical trial results to support a therapeutic hypothesis.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 17,
      "from": 17,
      "beatId": "8d5936cb-27f0-4627-8282-a3725663b41f",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Why Now",
      "beatSlug": "sequoia-pitch-why-now",
      "evidence": "Slide 17 explains why now is the right time for THB001, with mast cells central to asthma pathophysiology",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 17,
      "from": 17,
      "name": "Why Now",
      "slug": "15-why-now",
      "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
      "matchId": "98972dd9-1687-4557-8be5-15d52228175b",
      "evidence": "Slide 17 explains why now is the right time for THB001, with mast cells central to asthma pathophysiology",
      "position": 1,
      "objective": "Why is now the right time for THB001?",
      "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
      "confidence": 0.7,
      "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}